The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Viri Sode
Cytomegalovirus Nosode, Herpes Simplex I and II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode · HUMAN HERPESVIRUS 5 16 [hp_X]/mL; HUMAN HERPESVIRUS 1 30 [hp_X]/mL; HUMAN HERPESVIRUS 2 30 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 15 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 15 [hp_C]/mL; RUBELLA VIRUS 16 [hp_X]/mL; HEPATITIS A VIRUS 30 [hp_X]/mL; HEPATITIS B VIRUS 30 [hp_X]/mL; HEPATITIS C VIRUS 30 [hp_X]/mL; HUMAN HERPESVIRUS 4 15 [hp_C]/mL; HUMAN HERPESVIRUS 3 15 [hp_C]/mL · Spray · Oral · Nutritional Specialties, Inc.
NDC 83027-0304-01 · 60 mL in 1 BOTTLE, SPRAY · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cytomegalovirus Nosode, Herpes Simplex I and II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Nutritional Specialties, Inc. | HUMAN HERPESVIRUS 5 16 [hp_X]/mL; HUMAN HERPESVIRUS 1 30 [hp_X]/mL; HUMAN HERPESVIRUS 2 30 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 15 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 15 [hp_C]/mL; RUBELLA VIRUS 16 [hp_X]/mL; HEPATITIS A VIRUS 30 [hp_X]/mL; HEPATITIS B VIRUS 30 [hp_X]/mL; HEPATITIS C VIRUS 30 [hp_X]/mL; HUMAN HERPESVIRUS 4 15 [hp_C]/mL; HUMAN HERPESVIRUS 3 15 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| Nutritional Specialties, Inc. | HUMAN HERPESVIRUS 5 30 [hp_X]/mL; HUMAN HERPESVIRUS 1 30 [hp_X]/mL; HUMAN HERPESVIRUS 2 30 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 15 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 15 [hp_C]/mL; RUBELLA VIRUS 16 [hp_X]/mL; HEPATITIS A VIRUS 15 [hp_C]/mL; HEPATITIS B VIRUS 15 [hp_C]/mL; HEPATITIS C VIRUS 15 [hp_C]/mL; HUMAN HERPESVIRUS 4 15 [hp_C]/mL; HUMAN HERPESVIRUS 3 16 [hp_X]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Nutritional Specialties, Inc. | HEPATITIS A VIRUS 30 [hp_X]/mL; HEPATITIS B VIRUS 30 [hp_X]/mL; HEPATITIS C VIRUS 30 [hp_X]/mL; HUMAN HERPESVIRUS 1 30 [hp_X]/mL; HUMAN HERPESVIRUS 2 30 [hp_X]/mL; HUMAN HERPESVIRUS 3 15 [hp_C]/mL; HUMAN HERPESVIRUS 4 15 [hp_C]/mL; HUMAN HERPESVIRUS 5 16 [hp_X]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 15 [hp_C]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 15 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 15 [hp_C]/mL; RUBELLA VIRUS 16 [hp_X]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Viri Sode — NDC 83027-0304-01," retrieved September 3, 2026, https://drugdashboards.com/drug/83027030401.
Free to cite with attribution — see how the data is put together.